株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸器系疾患用医薬品:抗喘息薬・COPD薬・咳止め&風邪薬

Respiratory Diseases Drugs Global Market Report 2019

発行 The Business Research Company 商品コード 531335
出版日 ページ情報 英文 300 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.79円で換算しております。
Back to Top
呼吸器系疾患用医薬品:抗喘息薬・COPD薬・咳止め&風邪薬 Respiratory Diseases Drugs Global Market Report 2019
出版日: 2019年01月01日 ページ情報: 英文 300 Pages
概要

当レポートでは、世界の呼吸器系疾患用医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、薬剤/疾患区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 呼吸器系疾患用医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 抗喘息薬・COPD薬
    • 咳止め・風邪薬
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 呼吸器系疾患用医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • 喘息の有病者数:国別
  • 世界の一般開業医の数:国別
  • 市場収益 vs 一般開業医数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • GlaxoSmithKline
  • Novartis Ag
  • Pfizer Inc.
  • Boehringer Ingelheim
  • Astrazeneca Plc

第18章 主要M&A:呼吸器系疾患用医薬品市場

第19章 市場背景:医薬品市場

第20章 医薬品産業のファイナンシャルマージン

第21章 付録

目次

Respiratory Diseases Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Respiratory Diseases Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, respiratory diseases drugs indicators comparison.

Scope

Markets Covered: Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations

Companies Mentioned: GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson

Metrics Covered: Asthma Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, respiratory diseases drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends And Strategies

8. Respiratory Diseases Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Respiratory Diseases Drugs Market Regional Analysis

  • 9.1. Global Respiratory Diseases Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

10. Respiratory Diseases Drugs Market Segmentation

  • 10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Anti-Asthmatics And COPD Drugs
    • 10.1.2. Cough And Cold Preparations

11. Respiratory Diseases Drugs Market Metrics

  • 11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Respiratory Diseases Drugs Market

  • 12.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
  • 12.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics
    • 12.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
    • 12.7.1. China Respiratory Diseases Drugs Market
      • 12.7.1.1. China Respiratory Diseases Drugs Market Overview
      • 12.7.1.2. China Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Respiratory Diseases Drugs Market
      • 12.7.2.1. Australia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Respiratory Diseases Drugs Market
      • 12.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Respiratory Diseases Drugs Market
      • 12.7.4.1. India Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Respiratory Diseases Drugs Market
      • 12.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Respiratory Diseases Drugs Market
      • 12.7.6.1. Japan Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Respiratory Diseases Drugs Market
      • 12.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Respiratory Diseases Drugs Market
      • 12.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Respiratory Diseases Drugs Market
      • 12.7.9.1. Philippines Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Respiratory Diseases Drugs Market
      • 12.7.10.1. Singapore Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Respiratory Diseases Drugs Market
      • 12.7.11.1. South Korea Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Respiratory Diseases Drugs Market
      • 12.7.12.1. Thailand Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Respiratory Diseases Drugs Market
      • 12.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

  • 13.1. Western Europe Respiratory Diseases Drugs Market Overview
  • 13.2. Western Europe, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Respiratory Diseases Drugs Market Metrics
    • 13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis
    • 13.7.1. Austria Respiratory Diseases Drugs Market
      • 13.7.1.1. Austria Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Respiratory Diseases Drugs Market
      • 13.7.2.1. Belgium Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Respiratory Diseases Drugs Market
      • 13.7.3.1. Denmark Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Respiratory Diseases Drugs Market
      • 13.7.4.1. Finland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Respiratory Diseases Drugs Market
      • 13.7.5.1. France Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Respiratory Diseases Drugs Market
      • 13.7.6.1. Germany Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Respiratory Diseases Drugs Market
      • 13.7.7.1. Ireland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Respiratory Diseases Drugs Market
      • 13.7.8.1. Italy Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Respiratory Diseases Drugs Market
      • 13.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Respiratory Diseases Drugs Market
      • 13.7.10.1. Norway Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Respiratory Diseases Drugs Market
      • 13.7.11.1. Portugal Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Respiratory Diseases Drugs Market
      • 13.7.12.1. Spain Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Respiratory Diseases Drugs Market
      • 13.7.13.1. Sweden Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Respiratory Diseases Drugs Market
      • 13.7.14.1. Switzerland Respiratory Diseases Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Respiratory Diseases Drugs Market
      • 13.7.15.1. UK Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

  • 14.1. Eastern Europe Respiratory Diseases Drugs Market Overview
  • 14.2. Eastern Europe, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics
    • 14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Respiratory Diseases Drugs Market,
      • 14.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Respiratory Diseases Drugs Market
      • 14.7.2.1. Poland Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Respiratory Diseases Drugs Market
      • 14.7.3.1. Romania Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Respiratory Diseases Drugs Market
      • 14.7.4.1. Russia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

  • 15.1. North America Respiratory Diseases Drugs Market Overview
  • 15.2. North America, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Respiratory Diseases Drugs Market Metrics
    • 15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, North America Countries
  • 15.6. North America Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Respiratory Diseases Drugs Market: Country Analysis
    • 15.7.1. Canada Respiratory Diseases Drugs Market
      • 15.7.1.1. Canada Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Respiratory Diseases Drugs Market
      • 15.7.2.1. Mexico Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Respiratory Diseases Drugs Market
      • 15.7.3.1. USA Respiratory Diseases Drugs Market Overview
      • 15.7.3.2. USA Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

  • 16.1. South America Respiratory Diseases Drugs Market Overview
  • 16.2. South America, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Respiratory Diseases Drugs Market Metrics
    • 16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, South America Countries
  • 16.6. South America Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Respiratory Diseases Drugs Market: Country Analysis
    • 16.7.1. Argentina Respiratory Diseases Drugs Market
      • 16.7.1.1. Argentina Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Respiratory Diseases Drugs Market
      • 16.7.2.1. Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Respiratory Diseases Drugs Market
      • 16.7.3.1. Chile Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Respiratory Diseases Drugs Market
      • 16.7.4.1. Colombia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Respiratory Diseases Drugs Market
      • 16.7.5.1. Peru Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Respiratory Diseases Drugs Market
      • 16.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

  • 17.1. Middle East Respiratory Diseases Drugs Market Overview
  • 17.2. Middle East, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Respiratory Diseases Drugs Market Metrics
    • 17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Respiratory Diseases Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Respiratory Diseases Drugs Market
      • 17.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Respiratory Diseases Drugs Market
      • 17.7.2.1. Israel Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Respiratory Diseases Drugs Market
      • 17.7.3.1. Turkey Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Respiratory Diseases Drugs Market
      • 17.7.4.1. UAE Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

  • 18.1. Africa Respiratory Diseases Drugs Market Overview
  • 18.2. Africa, Respiratory Diseases Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Respiratory Diseases Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Respiratory Diseases Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Respiratory Diseases Drugs Market Metrics
    • 18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Respiratory Diseases Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Respiratory Diseases Drugs Market: Country Analysis
    • 18.7.1. Egypt Respiratory Diseases Drugs Market
      • 18.7.1.1. Egypt Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Respiratory Diseases Drugs Market
      • 18.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Respiratory Diseases Drugs Market
      • 18.7.3.1. South Africa Respiratory Diseases Drugs Market, 2014 - 2022, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. GlaxosmithKline Plc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Respiratory Diseases Drugs Market Structure And Strategy
      • 19.3.1.3. Company Respiratory Diseases Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. AstraZeneca Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Respiratory Diseases Drugs Market Structure And Strategy
      • 19.3.2.3. Company Respiratory Diseases Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Merck & Co
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Respiratory Diseases Drugs Market Structure And Strategy
      • 19.3.3.3. Company Respiratory Diseases Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Novartis AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Respiratory Diseases Drugs Market Structure And Strategy
      • 19.3.4.3. Company Respiratory Diseases Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Johnson & Johnson
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Respiratory Diseases Drugs Market Structure And Strategy
      • 19.3.5.3. Company Respiratory Diseases Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Respiratory Diseases Drugs Market In 2022- Growth Countries
  • 22.2. Global Respiratory Diseases Drugs Market In 2022- Growth Segments
  • 22.3. Global Respiratory Diseases Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top